Related Experiment Videos
[Neuronal cell damage in aceruloplasminemia]
1First Department of Medicine, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu, 431-3192 Japan.
Abstract:
Aceruloplasminemia is a newly recognized autosomal recessive disorder of iron metabolism that causes neurodegeneration of the retina and basal ganglia, as well as diabetes mellitus. The neurological symptoms in affected patients include involuntary movements, ataxia, and dementia reflecting the sites of iron deposition detected by MRI, and the regions of neurodegeneration observed at autopsy. Excess iron functions as a potent catalyst of biologic oxidation. CSF from affected patients revealed a threefold increased iron concentration associated with increased superoxide dismutase activity and lipid peroxidation products. We found that the amount of iron accumulated in various regions of the brain and visceral organs is correlated with the levels of the oxysterols, including 7-hydroxycholesterol, and 7-ketocholesterol, which are directly produced from cholesterol by active oxygen species. Positron emission tomography done on brains of aceruloplasminemia patients showed cortical glucose hypometabolism. Enzyme activities in the mitochondrial respiratory chain of the cerebral cortices of the patients were reduced to approximate 62% and 71%, respectively, for complexes I and IV. These findings suggest that iron-mediated free radicals contribute to lipid peroxidation and the impairment of mitochondrial energy metabolism in aceruloplasminemia.
Insights
Aceruloplasminemia, an iron metabolism disorder, causes neurodegeneration and diabetes. Excess iron leads to oxidative stress, damaging brain cells and impairing energy metabolism.
Area of Science:
- Neuroscience
- Metabolic Disorders
- Genetics
Background:
- Aceruloplasminemia is an autosomal recessive disorder impacting iron metabolism.
- It leads to neurodegeneration in the retina and basal ganglia, and diabetes mellitus.
- Neurological symptoms include movement disorders, ataxia, and dementia.
Observation:
- Increased iron concentration in cerebrospinal fluid (CSF) correlates with higher superoxide dismutase activity and lipid peroxidation.
- Brain iron deposition is linked to elevated oxysterol levels (7-hydroxycholesterol, 7-ketocholesterol).
- Positron emission tomography reveals cortical glucose hypometabolism in affected brains.
Findings:
- Iron accumulation acts as a catalyst for biologic oxidation, generating free radicals.
- Mitochondrial respiratory chain complexes I and IV show significant reductions in enzyme activity (62% and 71%).
- These factors contribute to lipid peroxidation and impaired mitochondrial energy metabolism.
Implications:
- Iron-mediated free radical damage is a key mechanism in aceruloplasminemia's pathogenesis.
- Understanding these mechanisms may guide therapeutic strategies for neurodegenerative diseases.
- Further research into iron chelation or antioxidant therapies could be beneficial.